Haemonetics
169 hedge funds and large institutions have $1.78B invested in Haemonetics in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 84 increasing their positions, 49 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
+6
Holders Change %
+3.68%
% of All Funds
4.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
84
Reduced
49
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$69.6M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$13.7M |
| 3 |
Goldman Sachs
New York
|
+$7.39M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.54M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.43M |
Top Sellers
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$59.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.1M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$9.82M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$8.33M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$7.8M |
